CID 3052751

Thiazolidine, 3-(4-(p-(2-bornyloxy)phenyl)butyl)-, hydrochloride

Structural Information

Molecular Formula
C23H35NOS
SMILES
CC1(C2CCC1(C(C2)OC3=CC=C(C=C3)CCCCN4CCSC4)C)C
InChI
InChI=1S/C23H35NOS/c1-22(2)19-11-12-23(22,3)21(16-19)25-20-9-7-18(8-10-20)6-4-5-13-24-14-15-26-17-24/h7-10,19,21H,4-6,11-17H2,1-3H3
InChIKey
HSUGSVFAAQGWDA-UHFFFAOYSA-N
Compound name
3-[4-[4-[(1,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl)oxy]phenyl]butyl]-1,3-thiazolidine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

373.24393 Da
Monoisotopic Mass

6.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 374.25121 191.7
[M+Na]+ 396.23315 200.0
[M+NH4]+ 391.27775 203.9
[M+K]+ 412.20709 191.3
[M-H]- 372.23665 195.6
[M+Na-2H]- 394.21860 196.7
[M]+ 373.24338 194.7
[M]- 373.24448 194.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.